Prot #P3-STS-01: A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects with Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either R

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

Effective start/end date6/11/146/11/17


  • PRA Health Sciences (Prot #P3-STS-01 // Prot #P3-STS-01)
  • CytRx Corporation (Prot #P3-STS-01 // Prot #P3-STS-01)